These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 15470234)
1. Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase. Németi B; Gregus Z Toxicol Sci; 2004 Dec; 82(2):419-28. PubMed ID: 15470234 [TBL] [Abstract][Full Text] [Related]
2. Reduction of arsenate to arsenite by human erythrocyte lysate and rat liver cytosol - characterization of a glutathione- and NAD-dependent arsenate reduction linked to glycolysis. Németi B; Gregus Z Toxicol Sci; 2005 Jun; 85(2):847-58. PubMed ID: 15788720 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols. Gregus Z; Roos G; Geerlings P; Németi B Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237 [TBL] [Abstract][Full Text] [Related]
4. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol. Gregus Z; Németi B Toxicol Sci; 2005 Jun; 85(2):859-69. PubMed ID: 15788719 [TBL] [Abstract][Full Text] [Related]
5. Arsenate reduction in human erythrocytes and rats--testing the role of purine nucleoside phosphorylase. Nemeti B; Csanaky I; Gregus Z Toxicol Sci; 2003 Jul; 74(1):22-31. PubMed ID: 12730608 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: I. The role of arsenolysis. Németi B; Gregus Z Toxicol Sci; 2009 Aug; 110(2):270-81. PubMed ID: 19474219 [TBL] [Abstract][Full Text] [Related]
7. Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Gregus Z; Németi B Toxicol Sci; 2002 Nov; 70(1):13-9. PubMed ID: 12388830 [TBL] [Abstract][Full Text] [Related]
8. Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase. Németi B; Gregus Z Toxicol Appl Pharmacol; 2009 Sep; 239(2):154-61. PubMed ID: 19248796 [TBL] [Abstract][Full Text] [Related]
9. Effect of an inactivator of glyceraldehyde-3-phosphate dehydrogenase, a fortuitous arsenate reductase, on disposition of arsenate in rats. Németi B; Csanaky I; Gregus Z Toxicol Sci; 2006 Mar; 90(1):49-60. PubMed ID: 16322075 [TBL] [Abstract][Full Text] [Related]
10. Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP. Németi B; Regonesi ME; Tortora P; Gregus Z Toxicol Sci; 2010 Oct; 117(2):270-81. PubMed ID: 20457661 [TBL] [Abstract][Full Text] [Related]
11. Reduction of arsenate to arsenite in hepatic cytosol. Németi B; Gregus Z Toxicol Sci; 2002 Nov; 70(1):4-12. PubMed ID: 12388829 [TBL] [Abstract][Full Text] [Related]
12. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats. Csanaky I; Gregus Z Toxicology; 2005 Feb; 207(1):91-104. PubMed ID: 15590125 [TBL] [Abstract][Full Text] [Related]
13. Glutathione-dependent reduction of arsenate by glycogen phosphorylase a reaction coupled to glycogenolysis. Németi B; Gregus Z Toxicol Sci; 2007 Nov; 100(1):36-43. PubMed ID: 17693425 [TBL] [Abstract][Full Text] [Related]
14. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors. Gregus Z; Németi B Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424 [TBL] [Abstract][Full Text] [Related]
15. Glucose metabolism is accelerated by exposure to t-butylhydroperoxide during NADH consumption in human erythrocytes. Ogasawara Y; Funakoshi M; Ishii K Blood Cells Mol Dis; 2008; 41(3):237-43. PubMed ID: 18706836 [TBL] [Abstract][Full Text] [Related]
16. Gene expression patterns as potential molecular biomarkers for malignant transformation in human keratinocytes treated with MNNG, arsenic, or a metal mixture. Bae DS; Handa RJ; Yang RS; Campain JA Toxicol Sci; 2003 Jul; 74(1):32-42. PubMed ID: 12773770 [TBL] [Abstract][Full Text] [Related]
17. Mitochondria work as reactors in reducing arsenate to arsenite. Németi B; Gregus Z Toxicol Appl Pharmacol; 2002 Aug; 182(3):208-18. PubMed ID: 12183100 [TBL] [Abstract][Full Text] [Related]
18. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Obrosova IG; Stevens MJ Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971 [TBL] [Abstract][Full Text] [Related]
19. Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Radabaugh TR; Sampayo-Reyes A; Zakharyan RA; Aposhian HV Chem Res Toxicol; 2002 May; 15(5):692-8. PubMed ID: 12018991 [TBL] [Abstract][Full Text] [Related]
20. HPLC analysis of human erythrocytic glutathione forms using OPA and N-acetyl-cysteine ethyl ester: evidence for nitrite-induced GSH oxidation to GSSG. Michaelsen JT; Dehnert S; Giustarini D; Beckmann B; Tsikas D J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(28):3405-17. PubMed ID: 19665947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]